Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of March 2025
The US FDA has approved a total of 2 new drug including 2 new molecular entities leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was GSK’s Blujepa securing approval for treating…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of January 2025
The US FDA has approved a total of 3 new drug including 2 new molecular entities and 1 biologic leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was Daiichi Sankyo &…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of December 2024
The US FDA has approved a total of 10 new drugs including 4 new molecular entities and 6 biologics leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was BMS’ Opdivo Qvantig…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of November 2024
The US FDA has approved a total of 5 new drugs including 4 new molecular entities and 1 biologic leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was Jazz Pharmaceuticals’ Ziihera…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of October 2024
The US FDA has approved a total of 4 new drugs including 2 new molecular entities and 2 biologics leading to the treatment of patients and advances in the healthcare industry
The major highlighted drugs were Pfizer’s Hympavzi for…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of September 2024
The US FDA has approved a total of 7 new drugs including 4 new molecular entities and 3 biologics leading to the treatment of patients and advances in the healthcare industry
The major highlighted drugs were Roche’s Tecentriq Hybreza & Ocrevus Zunovo for…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of August 2024
The US FDA has approved a total of 7 new drugs including 4 new molecular entities and 3 biologics leading to the treatments for patients and advances in the healthcare industry
The major highlighted drug was Johnson & Johnson’s Rybrevant plus Lazcluze…

